# Bristol-Myers Squibb Company (BMY) — Q2-2015 Earnings Results

**Report date:** 2015-07-23 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2015

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS — Stock Down 1.63%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.53 | N/A | +52.74% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their product performance despite market challenges. They emphasized the importance of their ongoing research and development efforts.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They acknowledged ongoing challenges in the market but expressed confidence in their pipeline.

### Guidance Changes

No forward guidance was provided during this earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a strong EPS beat, which indicates better-than-expected profitability. However, the stock fell by 1.63%, likely due to a lack of revenue details and no updated guidance. Investors may be cautious as the company navigates market challenges while focusing on its product pipeline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2015_